Results for Sickle Cell Anemia

1 - 10 of 21

Dr. Chou focuses on regenerative blood cellular therapy, the mechanisms of normal human hematopoietic development, and the pathophysiology of pediatric hematologic diseases.

E-mail:

chous [at] chop.edu

Stefano Rivella, PhD

Dr. Rivella is an expert in the pathophysiology of erythroid and iron disorders and in the generation of lentiviral vectors for the cure of hemoglobinopathies. He also investigates additional disorders such as anemia of inflammation and hemochromatosis.

E-mail:

rivellas [at] chop.edu

Timothy S. Olson, MD, PhD

Dr. Olson aims to improve diagnostics and treatment of bone marrow failure (BMF) syndromes, and to improve clinical hematopoietic stem cell transplantation (HSCT) outcomes. He conducts clinical trials of HSCT for non-malignant hematologic diseases. His laboratory explores both basic and translational research focused on genomics of BMF and the impact of BMF on hematopoietic niche function during HSCT.

E-mail:

olsont [at] chop.edu

Amaliris Guerra, PhD

Dr. Guerra is researching innovating therapies to treat β-thalassemia and sickle cell anemia and use lentiviruses as a tool. Her work aims to discover new biological targets that can be used to treat β-thalassemia and other forms of anemia.

E-mail:

gonzaleza2 [at] chop.edu

In The News: Food Allergies, Telemedicine, Parkway Run, Fungal Disease, Sickle Cell Documentary

Published on

Sep 30, 2022

in Cornerstone Blog

Learn about novel findings and new grants from Children’s Hospital of Philadelphia researchers.

First Potentially Curative Gene Therapy for Beta Thalassemia: Q&A with Janet Kwiatkowski, MD, MSCE

Published on

Sep 9, 2022

in Cornerstone Blog

In this Q&A, hematologist Dr. Kwiatkowski discusses the Food and Drug Administration approval of beti-cel (Zynteglo®), a gene therapy for beta thalassemia.